http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012107083-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7991750e6465371314796d528c72608
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D81-268
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
filingDate 2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e347766e62fbe6caced5cd6fef461d39
publicationDate 2012-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012107083-A1
titleOfInvention Stabilized package forms of sevelamer
abstract The invention relates to a package form for storing a sevelamer-comprising pharmaceutical composition, preferably a plurality of tablets, wherein said package form comprises a gas-impermeable first container adapted to contain a sevelamer-comprising pharmaceutical composition; and a gas-permeable second container adapted to contain a surface active material, such container being in gas contact with the first container.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104546781-A
priorityDate 2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0716606-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010189595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008062437-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0831857-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1676581-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006008651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1133989-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324842734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127557586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129408444

Total number of triples: 41.